However, several studies of KMT2Ar adult AML were not able to find differences in OS for KRAS-mut patients, which is most likely due to the relatively small sample size and a potential bias in the distribution of KRAS-mut [14, 17, 19]. Here, KRAS is linked to acute myeloid leukemia.